Chinese-american Bio Pharmaceutical Society is a 501(c)(3) organization based in San Francisco, California, registered in 2006, with $230,254 in FY2023 revenue. CharityIndex grades it B.
Revenue (FY2023)
$230K
▲ 54.6% vs prior year
Science & Tech median: $288K
Expenses (FY2023)
$245K
Net assets
$288K
Employees
—
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. Not scored for Chinese-american Bio Pharmaceutical Society— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Chinese-american Bio Pharmaceutical Society: 14 mo reserves · -6% margin earns a B+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. Not scored for Chinese-american Bio Pharmaceutical Society— this filing type doesn't report it, and the rating simply skips it (never counts it against the organization). See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Chinese-american Bio Pharmaceutical Society: 2 of 5 disclosure signals earns a C on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Revenue grew from $102K (FY2013) to $230K (FY2023) across 11 reported years.
Financial snapshot
Operating margin
-6.4%
Spent more than it raised in the latest fiscal year.
Total assets
$291K
Total liabilities
$2,500
Net assets
$288K
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $230,254▲54.6% | $244,893▲63.5% | $288,162▼4.8% | $290,662▼4.8% | 990 |
| 2022 | $148,904▲60.4% | $149,773▲231% | $302,801▼0.3% | $305,301 | 990EZ |
| 2021 | $92,810▲340% | $45,314▲77.7% | $303,661▲18.5% | $305,161▲18.6% | 990EZ |
| 2020 | $21,080▼74.9% | $25,502▼76.2% | $256,165▼1.7% | $257,365▼1.7% | 990EZ |
| 2019 | $83,890▼52.6% | $107,296▼23.4% | $260,587▼8.2% | $261,687▼9.9% | 990EZ |
| 2018 | $177,057▼9.8% | $140,101▲17.8% | $283,993▲15.0% | $290,493▲14.8% | 990EZ |
| 2017 | $196,370▲30.6% | $118,881▲13.0% | $247,037▲45.7% | $252,937▲49.2% | 990EZ |
| 2016 | $150,381▲12.1% | $105,202▼2.3% | $169,548▲36.3% | $169,548▲32.2% | 990EZ |
| 2015 | $134,189▲27.6% | $107,721▲11.5% | $124,369▲27.0% | $128,269▲24.9% | 990EZ |
| 2014 | $105,187▲3.2% | $96,600▲15.3% | $97,901▲9.6% | $102,701▲10.1% | 990EZ |
| 2013 | $101,927 | $83,783 | $89,314 | $93,314 | 990EZ |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Explore more
Data for Chinese-american Bio Pharmaceutical Society (EIN 20-2246060) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.